Literature DB >> 29113512

Diabetes based on 2-h plasma glucose among those classified as having prediabetes based on fasting plasma glucose or A1c.

Andy Menke1, Keith F Rust2, Catherine C Cowie3.   

Abstract

OBJECTIVE: Determine the prevalence of diabetes using 2-h plasma glucose among people who otherwise would be categorized as having prediabetes based on A1c and fasting glucose, and to determine whether those people were more likely to have cardiometabolic risk factors.
METHODS: Among 3644 adults with prediabetes based on A1c and fasting glucose in the 2005-2014 National Health and Nutrition Examination Survey, a cross-sectional survey of the US general population, we estimated the percentage who would be categorized as having diabetes based on having a 2-h plasma glucose ⩾200 mg/dL. We calculated odds ratios of cardiometabolic risk factors associated with having 2-h plasma glucose ⩾200 mg/dL.
RESULTS: A total of 6.9% would be categorized as having diabetes based on 2-h plasma glucose. The adjusted odds ratios (95% confidence interval) associated with having 2-h plasma glucose ⩾200 mg/dL were significant for total hypertension (2.06, 1.35-3.14), high triglycerides (1.64, 1.10-2.44), low high-density lipoprotein cholesterol (1.55, 1.01-2.39), albuminuria (2.05, 1.33-3.14) and elevated alanine aminotransferase (1.78, 1.09-2.91), but not for other cardiometabolic risk factors.
CONCLUSION: A total of 6.9% of people categorized as having prediabetes based on A1c and fasting glucose would be categorized as having diabetes based on 2-h plasma glucose. They were more likely to have hypertension, high triglycerides, low high-density lipoprotein cholesterol, albuminuria and elevated alanine aminotransferase.

Entities:  

Keywords:  Oral glucose tolerance test; cardiovascular risk factors; diagnostic criteria

Mesh:

Substances:

Year:  2017        PMID: 29113512     DOI: 10.1177/1479164117739316

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  6 in total

1.  Reproducibility of a prediabetes classification in a contemporary population.

Authors:  Chhavi Chadha; Anastassios G Pittas; Christine W Lary; William C Knowler; Ranee Chatterjee; Lawrence S Phillips; Vanita R Aroda; Michael R Lewis; Richard Pratley; Myrlene A Staten; Jason Nelson; Neda Rasouli; Irwin Brodsky
Journal:  Metabol Open       Date:  2020-03-07

Review 2.  Issues in Defining the Burden of Prediabetes Globally.

Authors:  Justin B Echouffo-Tcheugui; Andre P Kengne; Mohammed K Ali
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

Review 3.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

Review 4.  Prediabetes and What It Means: The Epidemiological Evidence.

Authors:  Justin B Echouffo-Tcheugui; Elizabeth Selvin
Journal:  Annu Rev Public Health       Date:  2021-12-23       Impact factor: 21.981

5.  Cross-Sectional and Longitudinal Association between Glycemic Status and Body Composition in Men: A Population-Based Study.

Authors:  Khaleal Almusaylim; Maggie Minett; Teresa L Binkley; Tianna M Beare; Bonny Specker
Journal:  Nutrients       Date:  2018-12-03       Impact factor: 5.717

6.  Anthropometry did not approach adequate predictive accuracies for detecting elevated fasting plasma glucose or hemoglobin A1c levels among Chinese children aged 7-9 years.

Authors:  Ying-Bin You; Hua Zhou; Jing Han; Yan-Hui Zhu; Ding Zan; Qing-Ying Zhang
Journal:  J Diabetes Investig       Date:  2020-09-29       Impact factor: 3.681

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.